Nuvectis Pharma Inc

Research Nuvectis Pharma Inc (NVCT) on Bullrun: market cap USD 756.77M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNVCT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 756.77M
• Financial periodFY2025
• Net income-USD 26.44M

Valuation Snapshot

latest market cap is USD 756.77M.

About Nuvectis Pharma Inc

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc.

Frequently asked questions

What is Nuvectis Pharma Inc's market cap?

Nuvectis Pharma Inc's market capitalization is USD 756.77M.

What does Nuvectis Pharma Inc do?

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.